Skip to Content
Merck
CN
  • E-Combretastatin and E-resveratrol structural modifications: antimicrobial and cancer cell growth inhibitory beta-E-nitrostyrenes.

E-Combretastatin and E-resveratrol structural modifications: antimicrobial and cancer cell growth inhibitory beta-E-nitrostyrenes.

Bioorganic & medicinal chemistry (2009-08-28)
Robin K Pettit, George R Pettit, Ernest Hamel, Fiona Hogan, Bryan R Moser, Sonja Wolf, Sandy Pon, Jean-Charles Chapuis, Jean M Schmidt
ABSTRACT

As part of a broad-based SAR investigation of E-resveratrol (strong sirtuin activator and antineoplastic) and the anticancer vascular-targeting combretastatin-type stilbenes, a series of twenty-three beta-E-nitrostyrenes was synthesized in order to evaluate potential antineoplastic, antitubulin, and antimicrobial activities. The beta-E-nitrostyrenes evaluated ranged from monosubstituted phenols to trimethoxy and 3-methoxy-4,5-methylenedioxy derivatives. Two of the beta-nitrostyrenes were synthesized as water-soluble sodium phosphate derivatives (4t, 4v). All except four (4r, 4s, 4t, 4u) of the series significantly inhibited a minipanel of human cancer cell lines. All but eight led to an IC(50) of <10 microM for inhibition of tubulin polymerization, and all except three (4l, 4t, 4v) displayed antimicrobial activity.

MATERIALS
Product Number
Brand
Product Description

Supelco
Resveratrol, analytical standard
Sigma-Aldrich
trans-β-Nitrostyrene, 99%
Sigma-Aldrich
Resveratrol, ≥99% (HPLC)